174 related articles for article (PubMed ID: 19821158)
1. Serum vascular endothelial growth factors a, C and d in human breast tumors.
Gisterek I; Matkowski R; Lacko A; Sedlaczek P; Szewczyk K; Biecek P; Halon A; Staszek U; Szelachowska J; Pudelko M; Bebenek M; Harlozinska-Szmyrka A; Kornafel J
Pathol Oncol Res; 2010 Sep; 16(3):337-44. PubMed ID: 19821158
[TBL] [Abstract][Full Text] [Related]
2. Measurement of circulating levels of VEGF-A, -C, and -D and their receptors, VEGFR-1 and -2 in gastric adenocarcinoma.
Al-Moundhri MS; Al-Shukaili A; Al-Nabhani M; Al-Bahrani B; Burney IA; Rizivi A; Ganguly SS
World J Gastroenterol; 2008 Jun; 14(24):3879-83. PubMed ID: 18609713
[TBL] [Abstract][Full Text] [Related]
3. Human Plasma Levels of VEGF-A, VEGF-C, VEGF-D, their Soluble Receptor - VEGFR-2 and Applicability of these Parameters as Tumor Markers in the Diagnostics of Breast Cancer.
Zajkowska M; Lubowicka E; Fiedorowicz W; Szmitkowski M; Jamiołkowski J; Ławicki S
Pathol Oncol Res; 2019 Oct; 25(4):1477-1486. PubMed ID: 30387014
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of serum vascular endothelial growth factor (VEGF) and microvessel density (MVD) as prognostic indicators in carcinoma breast.
Shivakumar S; Prabhakar BT; Jayashree K; Rajan MG; Salimath BP
J Cancer Res Clin Oncol; 2009 Apr; 135(4):627-36. PubMed ID: 18936974
[TBL] [Abstract][Full Text] [Related]
5. The evaluation of circulating endothelial progenitor cells and related angiogenic markers as prognostic factors in soft-tissue tumors.
Karampinis I; Joas E; Dreyer A; Ronellenfitsch U; Jakob J; Hohenberger P; Nowak K
Eur J Surg Oncol; 2018 Apr; 44(4):496-501. PubMed ID: 29397265
[TBL] [Abstract][Full Text] [Related]
6. Serum vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 as prognostic biomarkers for uterine cervical cancer.
Sawada M; Oishi T; Komatsu H; Sato S; Chikumi J; Nonaka M; Kudoh A; Osaku D; Harada T
Int J Clin Oncol; 2019 Dec; 24(12):1612-1619. PubMed ID: 31236742
[TBL] [Abstract][Full Text] [Related]
7. Circulating Angiogenic Factors as Biomarkers of Disease Severity and Bacterial Burden in Pulmonary Tuberculosis.
Kumar NP; Banurekha VV; Nair D; Babu S
PLoS One; 2016; 11(1):e0146318. PubMed ID: 26727122
[TBL] [Abstract][Full Text] [Related]
8. Circulating endothelial cells and circulating progenitor cells in breast cancer: relationship to endothelial damage/dysfunction/apoptosis, clinicopathologic factors, and the Nottingham Prognostic Index.
Goon PK; Lip GY; Stonelake PS; Blann AD
Neoplasia; 2009 Aug; 11(8):771-9. PubMed ID: 19649207
[TBL] [Abstract][Full Text] [Related]
9. Circulating levels of VEGF-A, VEGF-D and soluble VEGF-A receptor (sFIt-1) in human breast cancer.
Hoar FJ; Lip GY; Belgore F; Stonelake PS
Int J Biol Markers; 2004; 19(3):229-35. PubMed ID: 15503825
[TBL] [Abstract][Full Text] [Related]
10. Angiogenesis markers quantification in breast cancer and their correlation with clinicopathological prognostic variables.
Rykala J; Przybylowska K; Majsterek I; Pasz-Walczak G; Sygut A; Dziki A; Kruk-Jeromin J
Pathol Oncol Res; 2011 Dec; 17(4):809-17. PubMed ID: 21560015
[TBL] [Abstract][Full Text] [Related]
11. Pilot study to relate clinical outcome in pancreatic carcinoma and angiogenic plasma factors/circulating mature/progenitor endothelial cells: Preliminary results.
Vizio B; Novarino A; Giacobino A; Cristiano C; Prati A; Brondino G; Ciuffreda L; Bellone G
Cancer Sci; 2010 Nov; 101(11):2448-54. PubMed ID: 20950371
[TBL] [Abstract][Full Text] [Related]
12. Plasma vascular endothelial growth factors A and C in patients undergoing prostatic biopsy and TURP for suspected prostatic neoplasia.
Singh A; Gautam KA; Dalela D; Sankhwar S; Natu S; Sankhwar P; Srivastava A
Asian Pac J Cancer Prev; 2013; 14(3):2053-8. PubMed ID: 23679318
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma.
Gasparini G; Toi M; Gion M; Verderio P; Dittadi R; Hanatani M; Matsubara I; Vinante O; Bonoldi E; Boracchi P; Gatti C; Suzuki H; Tominaga T
J Natl Cancer Inst; 1997 Jan; 89(2):139-47. PubMed ID: 8998183
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of serum concentrations of vascular endothelial growth factor (VEGF) in breast cancer patients.
Hodorowicz-Zaniewska D; Kibil W; Małek A; Szpor J; Kulig J; Sztefko K
Pol J Pathol; 2012 Dec; 63(4):255-60. PubMed ID: 23359195
[TBL] [Abstract][Full Text] [Related]
15. Predictive significance of preoperative serum VEGF-C and VEGF-D, independently and combined with Ca19-9, for the presence of malignancy and lymph node metastasis in patients with gastric cancer.
Tsirlis TD; Kostakis A; Papastratis G; Masselou K; Vlachos I; Papachristodoulou A; Nikiteas NI
J Surg Oncol; 2010 Nov; 102(6):699-703. PubMed ID: 20672317
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer.
Kwon KA; Kim SH; Oh SY; Lee S; Han JY; Kim KH; Goh RY; Choi HJ; Park KJ; Roh MS; Kim HJ; Kwon HC; Lee JH
BMC Cancer; 2010 May; 10():203. PubMed ID: 20465852
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy and angiogenesis in advanced cancer: vascular endothelial growth factor (VEGF) decline as predictor of disease control during taxol therapy in metastatic breast cancer.
Lissoni P; Fugamalli E; Malugani F; Ardizzoia A; Secondino S; Tancini G; Gardani GS
Int J Biol Markers; 2000; 15(4):308-11. PubMed ID: 11192826
[TBL] [Abstract][Full Text] [Related]
18. [Study of mRNA expression of vascular endothelial growth factor-(A, C, D) genes and its effect on prognosis of breast cancer].
Zhang GH; Zeng Y; Yang WT; Shi DR
Zhonghua Bing Li Xue Za Zhi; 2006 Aug; 35(8):473-7. PubMed ID: 17069700
[TBL] [Abstract][Full Text] [Related]
19. Correlation Analysis of Nasopharyngeal Carcinoma TNM Staging with Serum EA IgA and VCA IgA in EBV and VEGF-C and -D.
Sun R; Wang X; Li X
Med Sci Monit; 2015 Jul; 21():2105-9. PubMed ID: 26191775
[TBL] [Abstract][Full Text] [Related]
20. Serum vascular endothelial growth factor/soluble vascular endothelial growth factor receptor 1 ratio is an independent prognostic marker in pancreatic cancer.
Chang YT; Chang MC; Wei SC; Tien YW; Hsu C; Liang PC; Tsao PN; Jan IS; Wong JM
Pancreas; 2008 Aug; 37(2):145-50. PubMed ID: 18665074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
